Page-TitleABOUT
non-opiod pain relief

REINVENTING HOW HEALTHCARE PROFESSIONALS AND PATIENTS MANAGE PAIN

Virpax Pharmaceuticals is committed to developing non-addictive product candidates that manage pain and its complexities, while minimizing risks to patients and society. Our proprietary delivery systems will reinvent how patients and prescribers manage pain worldwide.

Pain is a universal condition, while the perception of pain is unique. We are dedicated to creating novel non-addictive treatment options for the management of pain. By combining selected drug compounds with our cutting-edge delivery systems, we strive to maximize our products’ capabilities and successfully bring them to market.

NON-ADDICTIVE PRODUCTS

We are developing numerous drug development strategies that will address the rising need for alternatives to addictive opioid prescription medications. Our robust pipeline harnesses the improved characteristics of the Molecular Envelope Technology (MET), the topical spray film, and the liposomal hydrogel drug-delivery technologies to target pain at its source.

CNS GROWTH OPPORTUNITIES

Our MET platform is being used to grow our Central Nervous System (CNS) disorder pipeline. These additional patented formulations include neurotransmission and neuroprotective actives. The current product candidates include Post Traumatic Stress Disorder (PTSD), and epilepsy in children (Rare Pediatric Disease) and adults. In the future, the MET will be used to deliver actives that will be developed to manage other neurodegenerative disorders.

CalloutNOVELDRUG-DELIVERYTECHNOLOGIES
Learn more
new drug delivery systems
CalloutNOVELDRUG-DELIVERYTECHNOLOGIES
Learn more

“Biopharma companies have a deep understanding of the R&D of novel products, making the industry essential to the advancement of public health initiatives.”

ANTHONY P. MACK
CEO of Virpax Pharmaceuticals
CalloutPRESCRIBERS AND PATIENTS ARESEEKING ALTERNATIVESTO CURRENT PAIN TREATMENTS
SubheadAREAS OF FOCUS

We are developing novel drug delivery technologies and we are continuously strengthening our worldwide patents in the development of non-addictive treatments for pain and degenerative neurological disorders.

BRINGING THE BEST MINDS TOGETHER

Our team has over 100 years of combined executive experience in the pharmaceutical industry and extensive knowledge in developing and commercializing pharmaceutical products.

Learn more

DISCOVER THE BENEFITS OF OUR LATEST TECHNOLOGY ADVANCEMENTS

LEARN MORE

DISCOVER THE BENEFITS OF OUR LATEST TECHNOLOGY ADVANCEMENTS

LEARN MORE